Christoph Westphal has stepped down as CEO of Sirtris Pharmaceuticals, which was acquired by GlaxoSmithKline for around $720 million two years ago. He now will become head of GSK venture capital arm SR One Ltd.
Westphal also is one of three founding principals of Longwood Founders Fund, a new Boston VC firm that has raised over $50 million for its debut fund (reportedly GSK is among the backers). The other Longwood co-founders are former Sirtris execs Michelle Dipp and Rich Aldrich.
Prior to Sirtris, Westphal was with Polaris Venture Partners. www.gsk.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: